-
One-time screening for abdominal aortic Aneurysms (AAA) is recommended in older men, but there is little long-term data on the value of such screening, especially in women.
-
The home automatic external defibrillator trial (HAT) tested the hypothesis that placement of an automatic external defibrillator (AED) in the homes of patients with previous myocardial infarctions, who were thought to be at moderate risk for sudden death, would reduce overall mortality compared to standard measures to train family members in manual cardiopulmonary resuscitation (CPR).
-
Intravascular volume expansion has long been advised as an effective temporizing technique for patients with cardiac tamponade prior to drainage of the fluid, but there is little data supporting this practice.
-
Kim YH. Health benefits of Tai Chi. 2008;11:53-56.
-
-
Two Duke University Medical Center researchers tackle the question "Is it ethical to conduct clinical trials with patients in a hospice environment?" in the Feb. 4, 2008, "Professional Issues" section of the American Medical News web site.
-
When patients are medically ready to leave the acute care hospital and have no coverage for post-acute care, it's a "no-brainer" for the hospital to pay to move the patient to a lower level of care, says Jay Cayner, director of social patient and family services at the University of Iowa Hospitals and Clinics.
-
As health insurance costs escalate and employers reduce coverage for employees, raise deductibles, or stop providing health insurance altogether, hospitals are providing care for an increasing number of patients who have no means to pay.
-
With more than $370 million in overpayments identified in fiscal year 2007 by auditors in the Recovery Audit Contractor (RAC) demonstration project, the Centers for Medicare and Medicaid Services (CMS) has designated the project a success and is making plans to expand the program beyond the three states in the demonstration project.
-
An analysis of decades of drug approvals, published in the New England Journal of Medicine, provides the first scientific evidence supporting complaints that medications approved on deadline by the Food and Drug Administration (FDA) are more likely to cause safety problems than drugs approved prior to a deadline date.
